HRTX Exercise Disclosure
Hensley Mark Earl · SEC Form 4 · Filed Nov 3, 2026
Exercise
Calculated transaction value
$0
Hensley Mark Earl Chief Operating Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
HRTX daily price context
Close on/before transaction
$0.28
Oct 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 11,770 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-444831
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$937.72
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 30, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Disposition | Oct 30, 2026 | $937.72 |
| Heron Therapeutics, Inc. /de/ HRTX Current | Exercise | Oct 30, 2026 | $0 |